Abstract
Cells typically vary in their response to extracellular ligands. Receptor transport processes modulate ligand-receptor induced signal transduction and impact the variability in cellular responses. Here, we quantitatively characterized cellular variability in erythropoietin receptor (EpoR) trafficking at the single-cell level based on live-cell imaging and mathematical modeling. Using ensembles of single-cell mathematical models reduced parameter uncertainties and showed that rapid EpoR turnover, transport of internalized EpoR back to the plasma membrane, and degradation of Epo-EpoR complexes were essential for receptor trafficking. EpoR trafficking dynamics in adherent H838 lung cancer cells closely resembled the dynamics previously characterized by mathematical modeling in suspension cells, indicating that dynamic properties of the EpoR system are widely conserved. Receptor transport processes differed by one order of magnitude between individual cells. However, the concentration of activated Epo-EpoR complexes was less variable due to the correlated kinetics of opposing transport processes acting as a buffering system.
MeSH terms
-
Biological Transport / physiology*
-
Cell Line, Tumor
-
Computational Biology
-
Fluorescent Dyes / analysis
-
Fluorescent Dyes / chemistry
-
Fluorescent Dyes / metabolism
-
Humans
-
Image Processing, Computer-Assisted / methods
-
Kinetics
-
Microscopy, Confocal
-
Models, Biological*
-
Receptors, Cell Surface / analysis
-
Receptors, Cell Surface / chemistry
-
Receptors, Cell Surface / metabolism*
-
Receptors, Erythropoietin
-
Single-Cell Analysis / methods*
Substances
-
Fluorescent Dyes
-
Receptors, Cell Surface
-
Receptors, Erythropoietin
Grants and funding
This work was supported by the German Federal Ministry of Education and Research (BMBF,
www.bmbf.de) via the MedSys-Network LungSys II (
http://www.lungsys.de, FKZ 0316042C), SysTec-EpiSys (
http://www.episys.org, FKZ 0315502D), the e:Bio RNA-CODE joint research project (FKZ 031A298), and an e:Bio junior group grant, the German Center for Lung Research [Deutsches Zentrum für Lungenforschung (DZL),
www.dzl.de], the German Research Foundation (DFG, EXC81), and by the Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology / SBCancer (
www.helmholtz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.